Thus, longitudinal studies involving serum lipid examination and MANF/EWSR1/ANXA6 pathway assessment are needed to further explain the possible role of hypolipidemia in the pathogenesis of MDD. The gene discussed is ANXA6; the disease is major depressive disorder.